$3.17
$0.00 (0.00%)
End-of-day quote: 05/18/2024
NasdaqCM:DMAC
DiaMedica Therapeutics Annual Report
| Year | Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2013 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$0.00M | $0.00M | $0.00M | $0.00M | $0.50M | $0.00M | $0.00M | $0.00M | ||
| GM % | Gross Margin % |
|
0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 0.00% | 0.00% | 0.00% | ||
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||
| EPS | Earnings Per Share |
|
$0.00 | $-0.60 | $-0.52 | $-0.65 | $-0.78 | $-0.89 | $-0.74 | $-0.80 | $-0.40 | $-2.55 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Sha. | Shares |
|
26.44m | -82.55m | 18.75m | 12.01m | 11.96m | 6.37m | 5.53m | 2.93m | ||
| OCF | Operating Cash Flow |
|
$-11.51M | $-12332000.00M | $-9.19M | $-9.10M | $-5.70M | $-3.90M | $-3.02M | $-5.86M | ||
| FCF | Free Cash Flow |
|
$-11.59M | $-12352000.00M | $-9.24M | $0.00M | $-7.65M | $-3.92M | $-3.03M | $-5.88M | ||
| FCFS | Free Cash Flow Per Share |
|
$-0.44 | $-0.59 | $-0.59 | $-0.76 | $-0.74 | $-0.66 | $-0.64 | $-2.20 |
